Cadre (CDRE) vs TriMas (TRS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 7, 2026.
Summary
TriMas (TRS) has outperformed Cadre (CDRE) over the past year, gaining 2.9% versus a loss of 33.6%. TriMas is the larger company by market cap ($1.37 billion vs $1.07 billion), about 1.3 times the size. On valuation, Cadre trades at a lower forward P/E (15.2x vs 18.0x for TriMas).
Cadre offers the higher dividend yield (1.56% vs 0.42%).
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | CDRE | TRS |
|---|---|---|
| Share price | $24.97 | $38.25 |
| Market cap | $1.07B | $1.37B |
| 1-day change | -2.08% | -1.85% |
| YTD return | -38.86% | +7.90% |
| 1-year return | -33.64% | +2.88% |
| 5-year return | — | +21.70% |
| P/E ratio (TTM) | 30.83 | 15.55 |
| Forward P/E | 15.21 | 17.97 |
| EPS (TTM) | $0.81 | $2.46 |
| Dividend yield | 1.56% | 0.42% |
| Annual dividend | $0.39 | $0.16 |
| 52-week high | $48.76 | $45.43 |
| 52-week low | $24.42 | $30.43 |
| Distance from 52-week high | -48.79% | -15.80% |
| Average volume | 408.06K | 369.53K |
| Shares outstanding | 42.82M | 35.87M |
| Sector | Health Care | Industrials |
| Industry | Industrial Specialties | Industrial Specialties |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- TRS has outperformed CDRE by 36.5 percentage points over the past year.
- Cadre trades at a higher earnings multiple (30.8x vs 15.5x trailing P/E).
- Cadre offers a meaningfully higher dividend yield (1.56% vs 0.42%).
- The two companies sit in different sectors: Cadre in Health Care and TriMas in Industrials.
CDRE vs TRS FAQ
Which is bigger, Cadre or TriMas?
TriMas (TRS) is larger, with a market capitalization of $1.37B compared with $1.07B for Cadre (CDRE).
Which stock has performed better over the past year, CDRE or TRS?
TRS returned +2.88% over the past 12 months, compared with -33.64% for CDRE (price return, excluding dividends). Past performance does not predict future results.
Which has the lower P/E ratio, CDRE or TRS?
TRS has the lower trailing P/E at 15.5, versus 30.8 for CDRE. A lower P/E is not by itself a sign of a better investment; it can reflect slower expected growth or higher risk.
Which pays a higher dividend, Cadre or TriMas?
Cadre has the higher yield at 1.56%, compared with 0.42% for TriMas.
Are Cadre and TriMas in the same industry?
Yes. Both are classified in the Industrial Specialties industry within the Health Care sector.